Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1540 of 6351
-
Brain pacemaker aims to curb opioid cravings
Disease control Recruiting nowThe purpose of this study is to determine if personalized (adaptive) Deep Brain Stimulation (DBS) based upon invasive brain mapping is safe and can lead to better outcomes like reductions in craving and opioid use.
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control Recruiting nowQLC5508 is a fully humanized IgG1 antibody-drug conjugate (ADC) which specifically binds to B7-H3, a target wildly expressed on solid tumor cells. The objectives of this study are to investigate the safety, tolerability, pharmacokinetics and anti-tumor activity of QLC5508 in comb…
Phase 1/2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Amniotic grafts show promise for chronic wounds in large Real-World study
Disease control OngoingThis retrospective multi-site observational cohort study uses electronic health records (EHR) from U.S. wound care centers to evaluate the effectiveness of four amniotic membrane allografts (Acesso DL, Acesso TL, Neostim DL, Neostim TL) when added to standard wound care for diabe…
Sponsor: Dynamic Medical Services dba Acesso Biologics • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New pill could ease Post-Surgery pain without opioids
Symptom relief Recruiting nowThis is a phase II/III, multi-center, randomized, double-blind, comparator-controlled study to evaluate the efficacy and safety of HRS-2129 for postoperative pain management in abdominal surgery.
Phase 2/3 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
AI spots hidden brain aneurysms in routine scans
Diagnosis OngoingThe goal of this clinical trial is to verify the opportunistic screening potential of the AI software for detection of brain unruptured intracranial aneurysms (UIA) on routinely performed brain NECT scans in a prospective setting in the Belgian population. The main question the …
Sponsor: Ziekenhuis Oost-Limburg • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
New parenting program aims to stop teen emotional problems before they start
Prevention Recruiting nowThe aim of this study is to conduct a multi-country randomized waitlist controlled trial to evaluate the effectiveness, cost-effectiveness, and scalability of the optimized Parenting for Lifelong Health (PLH) for Parents and Teens program in Moldova and North Macedonia. In Phase …
Sponsor: University of Klagenfurt • Aim: Prevention
Last updated Jun 27, 2026 13:01 UTC
-
New talk therapy aims to calm End-of-Life fears in advanced cancer patients
Symptom relief Recruiting nowThe psychological challenges faced by patients with incurable cancer and their caregivers include an uncertain future, fear of dying and uncontrollable suffering, grief, and loneliness. In a significant subgroup, this challenge is associated with significant fear and existential …
Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Can a smartphone app curb teen suicide risk?
Symptom relief By invitation onlyThe primary objective of this study is to assess the efficacy of a digital intervention in reducing suicidal ideation in adolescents.
Sponsor: Oui Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Dissolvable heart scaffolds take on drug balloons in major artery showdown
Disease control Not yet recruitingThis study plans to enroll 150 patients who are candidates for "intervention without implantation" therapy and they will be randomly assigned in a 1:1 ratio to either the new-generation Firesorb scaffold group (BRS group, N=75) or the drug-coated balloon group (DCB group, N=75). …
Sponsor: Xuzhou Third People's Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:45 UTC
-
Could a daily pill replace needles for hemophilia a?
Disease control Recruiting nowThis study will test how different doses of study medicine (Inno8) work in the bodies of people with haemophilia A. The purpose of the study is to see if Inno8 is safe to use for people with haemophilia A. The study medicine is a new medicine that cannot yet be prescribed by doct…
Phase 1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can magnetic waves tame autoimmune disease? new trial begins
Disease control By invitation onlyThe ImmuneNet study is a Phase I/II clinical trial sponsored by Truway Health, Inc. It will test whether gentle, low-frequency electromagnetic resonance (LF-EMR) can influence how immune cells communicate and synchronize with each other. The goal is to see if this "quantum-synapt…
Phase 1/2 • Sponsor: Truway Health, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Smart scale for swelling: could a Foot-Volume monitor keep heart patients out of hospital?
Disease control Recruiting nowThis pragmatic randomized crossover trial looks at the effect(s) of using a remote patient monitoring device (Heartfelt device) with health alerts to monitor the development of peripheral edema in patients with heart failure (HF). The hypothesis is that this passive measurement m…
Sponsor: Heartfelt Technologies • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New heart device aims to clear toughest blockages
Disease control Recruiting nowClinical research with medical devices indicated in accordance with the CE marking, led by researchers, multicenter, open, prospective, randomized and controlled. Patients are randomized to treatment with a conventional balloon and then a coronary stent or to initial plaque modif…
Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Brain zaps for depression in schizophrenia: new trial underway
Symptom relief Recruiting nowThe purpose of this study is to provide an effective repetitive transcranial magnetic stimulation (rTMS) treatment for depressive symptoms in patients with schizophrenia. Schizophrenia patients with depressive symptoms will be exposed to rTMS to improve their symptoms.
Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Heart failure in women: could a social worker be the missing prescription?
Disease control Recruiting nowBackground: Heart Failure (HF) is the second most common cause of hospitalizations for women in North America. Non-adherence to guideline-directed medical therapy (GDMT) is associated with 50% of all treatment failures and high rates of hospitalizations and death. A recent Canadi…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Can a laser beam save your tooth and ease pain better than traditional methods?
Disease control OngoingThis study compares two methods used during full pulpotomy, a treatment for teeth with deep tooth decay that has exposed the dental pulp. In the first method, the dentist removes the affected pulp tissue using a high-speed dental bur and then controls the bleeding using a sodium…
Sponsor: King Abdullah University Hospital • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New hope for kids with AML: gentler chemo combos under trial
Disease control Recruiting nowThis research study investigates the tolerability of substituting two cycles of chemotherapy into the standard pediatric acute myeloid leukemia (AML) chemotherapy treatment regimen for patients with newly diagnosed AML at intermediate-risk (IR) and high-risk (HR) of relapse. The …
Early phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New radioactive drug targets FAP-Positive tumors in early trial
Disease control Recruiting nowThis is a study of LY4337713 in participants with certain types of cancer that is advanced or has spread. Participants must have cancer with high levels of a protein called fibroblast activation protein (FAP). The purpose of this study is to evaluate safety, side effects, and eff…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Could a common probiotic soothe IBS? new trial seeks answers
Symptom relief Recruiting nowThis is a double-blind, randomized (group assignment by chance), placebo-controlled, multicenter trial which will be conducted over a 13.5-months period The main objective of the research is to demonstrate the efficacy of Saccharomyces boulardii CNCM I-745 on global IBS symptoms,…
Phase 3 • Sponsor: Biocodex • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Can targeted exercises boost relief for cubital tunnel syndrome?
Symptom relief CompletedCubital tunnel syndrome occurs when the ulnar nerve is compressed or irritated near the elbow. It can cause elbow or forearm pain, numbness or tingling in the ring and little fingers, hand weakness, and difficulty performing daily activities. This randomized clinical trial will …
Sponsor: Hamna Sarfraz • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC